Anthony Mattacchione

Global Chief Financial Officer at CellCarta

Anthony Mattacchione currently serves as the Chief Financial Officer at Caprion-HistoGenex, a position held since October 2020. Prior to this role, Anthony was the Senior Vice President and Chief Financial Officer at AMRI from April 2018 to May 2020 and at Bruker from February 2013 to April 2018, where responsibilities encompassed investor relations, corporate development, and financial planning. Before joining Bruker, Anthony held various financial leadership roles at MilliporeSigma and Gerber Scientific Inc., and began a career in finance as a Senior Auditor at PricewaterhouseCoopers. Anthony holds an MBA in Finance from the University of Connecticut and a BS in Accountancy from Central Connecticut State University.

Links